BioDelivery Sciences International, Inc. (BDSI)
BDSI Price and Sentiment
BDSI Latest news
BioDelivery Sciences International (BDSI) is a Top-Ranked Momentum Stock: Should You Buy?
2021-09-21 13:08The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
4 Penny Stocks To Buy According To Analysts & Price Targets Up To 507%
2021-09-14 12:21Biotech Penny Stocks Surge As Sector Reverses Course The post 4 Penny Stocks To Buy According To Analysts & Price Targets Up To 507% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Best Reddit Penny Stocks To Buy Now? 5 For Your List In September 2021
2021-09-12 15:15Which Reddit penny stocks are on your watchlist right now? The post Best Reddit Penny Stocks To Buy Now?
BioDelivery Sciences: Legal Fees Are Causing My Pain
2021-09-09 10:02Share price performance has been a massive disappointment since I last covered the stock. I provide my updated valuation of BDSI to represent the acquisition of US and Canadian rights to ELYXYB. My model shows shares are trading at a discount of ~67%.
BioDelivery Sciences to Exhibit Three Scientific Posters Comparing BELBUCA® to Oxycodone at the PAINWeek 2021 Conference
2021-09-07 09:28RALEIGH, N.C., Sept. 07, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, will showcase three scientific posters regarding BELBUCA® (buprenorphine buccal film), CIII at the PAINWeek 2021 Conference taking place September 7 – 11, 2021 at The Cosmopolitan of Las Vegas.
BioDelivery (BDSI) Up 3.2% Since Last Earnings Report: Can It Continue?
2021-09-03 12:59BioDelivery (BDSI) reported earnings 30 days ago. What's next for the stock?
BioDelivery Sciences to Participate in Upcoming Virtual Investor Conferences
2021-09-03 08:00RALEIGH, N.C., Sept. 03, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeffrey Bailey, Chief Executive Officer, and Terry Coelho, Executive Vice President and Chief Financial Officer, will present and participate in one-on-one investor meetings at the H.C. Wainwright 23rd Annual Global Investment Conference taking place on September 13-15 and the Cantor Fitzgerald Global Healthcare Conference taking place on September 27-30.
BioDelivery Sciences: Yet Another Buying Opportunity
2021-08-27 16:36BDSI trades at extremely low P/E and EV/S ratios for a company that is still growing at a good clip.
Top Penny Stocks You Need to Know About Right Now
2021-08-20 13:00Are these top penny stocks on your small-caps watchlist The post Top Penny Stocks You Need to Know About Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
BioDelivery Sciences International (BDSI) is a Top-Ranked Momentum Stock: Should You Buy?
2021-08-10 12:24Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.